The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 03, 2013
Filed:
Dec. 29, 2009
Ramakrishna Nirogi, Hyderabad, IN;
Abdul Rasheed Mohammed, Hyderabad, IN;
Ishtiyaque Ahmad, Hyderabad, IN;
Pradeep Jayarajan, Hyderabad, IN;
Nagaraj Vishwottam Kandikere, Hyderabad, IN;
Anil Karbhari Shinde, Hyderabad, IN;
Rama Sastri Kambhampati, Hyderabad, IN;
Gopinadh Bhyrapuneni, Hyderabad, IN;
Jyothsna Ravula, Hyderabad, IN;
Sriramachandra Murthy Patnala, Hyderabad, IN;
Venkateswarlu Jasti, Hyderabad, IN;
Ramakrishna Nirogi, Hyderabad, IN;
Abdul Rasheed Mohammed, Hyderabad, IN;
Ishtiyaque Ahmad, Hyderabad, IN;
Pradeep Jayarajan, Hyderabad, IN;
Nagaraj Vishwottam Kandikere, Hyderabad, IN;
Anil Karbhari Shinde, Hyderabad, IN;
Rama Sastri Kambhampati, Hyderabad, IN;
Gopinadh Bhyrapuneni, Hyderabad, IN;
Jyothsna Ravula, Hyderabad, IN;
Sriramachandra Murthy Patnala, Hyderabad, IN;
Venkateswarlu Jasti, Hyderabad, IN;
Suven Life Sciences Limited, Hyderabad, IN;
Abstract
The present invention relates to novel 1,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The compounds of the present invention are useful in the treatment/prevention of various disorders that are mediated by 5-HT4 receptor activity.